# Tackling Resistance And HealthCare Economics Through CPE Screening

> **NCT07663110** · NA · NOT_YET_RECRUITING · sponsor: **Imperial College London** · enrollment: 16000 (estimated)

## Conditions studied

- Carbapenem-Resistant Enterobacteriaceae
- Colonisation

## Interventions

- **DIAGNOSTIC_TEST:** Rapid molecular diagnostic test for CPE identification

## Key facts

- **NCT ID:** NCT07663110
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2027-11-01
- **Final completion:** 2028-03-31
- **Target enrollment:** 16000 (ESTIMATED)
- **Last updated:** 2026-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07663110

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07663110, "Tackling Resistance And HealthCare Economics Through CPE Screening". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07663110. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*